Concepts (52)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Metal Nanoparticles | 3 | 2025 | 137 | 0.890 |
Why?
|
| Vaccines, DNA | 3 | 2020 | 11 | 0.880 |
Why?
|
| Dendritic Cells | 3 | 2020 | 144 | 0.670 |
Why?
|
| Gold | 3 | 2025 | 137 | 0.630 |
Why?
|
| Nanoconjugates | 1 | 2019 | 18 | 0.590 |
Why?
|
| Melanoma, Experimental | 2 | 2020 | 31 | 0.310 |
Why?
|
| Gene Transfer Techniques | 1 | 2025 | 74 | 0.230 |
Why?
|
| Drug Delivery Systems | 2 | 2025 | 236 | 0.220 |
Why?
|
| RNA, Messenger | 1 | 2025 | 668 | 0.200 |
Why?
|
| Cell Line, Tumor | 3 | 2025 | 1360 | 0.180 |
Why?
|
| Endosomes | 2 | 2025 | 53 | 0.170 |
Why?
|
| Mannose-Binding Lectins | 1 | 2020 | 4 | 0.170 |
Why?
|
| Lectins, C-Type | 1 | 2020 | 45 | 0.160 |
Why?
|
| Receptors, Cell Surface | 1 | 2020 | 114 | 0.160 |
Why?
|
| Mice | 5 | 2025 | 4845 | 0.150 |
Why?
|
| Immunity, Active | 1 | 2019 | 4 | 0.150 |
Why?
|
| MART-1 Antigen | 1 | 2019 | 3 | 0.150 |
Why?
|
| Sulfhydryl Compounds | 1 | 2019 | 30 | 0.150 |
Why?
|
| Lipids | 1 | 2020 | 220 | 0.150 |
Why?
|
| Skin Neoplasms | 1 | 2020 | 147 | 0.150 |
Why?
|
| Bone Marrow Cells | 1 | 2019 | 81 | 0.140 |
Why?
|
| Plasmids | 1 | 2019 | 126 | 0.140 |
Why?
|
| Fluorescent Dyes | 1 | 2019 | 93 | 0.140 |
Why?
|
| Liposomes | 2 | 2016 | 145 | 0.140 |
Why?
|
| Animals | 6 | 2025 | 10756 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 1672 | 0.130 |
Why?
|
| Nanoparticles | 1 | 2020 | 292 | 0.120 |
Why?
|
| Cytokines | 1 | 2019 | 456 | 0.120 |
Why?
|
| Ovarian Neoplasms | 1 | 2022 | 607 | 0.120 |
Why?
|
| Cells, Cultured | 1 | 2019 | 1022 | 0.120 |
Why?
|
| Cancer Vaccines | 1 | 2015 | 33 | 0.120 |
Why?
|
| Curcumin | 1 | 2016 | 69 | 0.110 |
Why?
|
| Paclitaxel | 1 | 2016 | 201 | 0.110 |
Why?
|
| Drug Carriers | 1 | 2016 | 119 | 0.110 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 686 | 0.080 |
Why?
|
| Female | 3 | 2022 | 15740 | 0.070 |
Why?
|
| Neoplasms | 1 | 2015 | 882 | 0.060 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2025 | 40 | 0.060 |
Why?
|
| Endocytosis | 1 | 2025 | 97 | 0.060 |
Why?
|
| Male | 1 | 2019 | 14049 | 0.050 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2022 | 31 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2022 | 137 | 0.050 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2022 | 83 | 0.050 |
Why?
|
| Insulin | 1 | 2022 | 325 | 0.040 |
Why?
|
| Molecular Conformation | 1 | 2020 | 67 | 0.040 |
Why?
|
| Humans | 3 | 2025 | 29078 | 0.030 |
Why?
|
| Micelles | 1 | 2016 | 19 | 0.030 |
Why?
|
| Immunotherapy, Active | 1 | 2015 | 6 | 0.030 |
Why?
|
| CD11c Antigen | 1 | 2015 | 10 | 0.030 |
Why?
|
| Biomimetics | 1 | 2015 | 8 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2016 | 271 | 0.030 |
Why?
|
| Polymers | 1 | 2016 | 118 | 0.030 |
Why?
|